Plunkett Research Online: OncoCyte

ONCOCYTE (OCX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers......


ONCOCYTE

Ticker: OCX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 510 775-0515
Fax:
Address: 15 Cushing
Irvine, CA 92618 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Joshua RiggsCEO/Director/President
Andrea JamesCFO
See More
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers......See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture